News

The LimFlow System for TADV (Transcatheter Arterialization of Deep Veins) is designed to reestablish blood flow in deep veins for “no-option” CLTI patients who have exhausted all other treatment methods and face major amputation of their...

The BVA-100 (Blood Volume Analyzer) quantifies circulating blood volume utilizing the gold standard methodology, the indicator tracer dilution technique.

The study, which involves the largest analysis of blood RNA from patients with angiographically confirmed CAD, adds several novel dimensions to the current understanding of heart disease and could one day lead to a simple blood test that...

More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men.

Left atrial appendage closure is a minimally invasive procedure that is used to reduce the risk of stroke associated with atrial fibrillation.

The process of hemostasis involves two main components: First, blood platelets attach to the wound edges, form a plug and provisionally seal the injury. Secondly, blood coagulation or the coagulation cascade is initiated, leading to the...

The data, presented by JoAnn Lindenfeld, MD, focused on the efficacy of the MobiusHD device implantation in progressive heart failure patients who were previously highly symptomatic despite guideline-directed medical therapy.

Getinge iCast™ Covered Stent System has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the treatment of patients with iliac arterial occlusive disease. As the most clinically evaluated balloon...

With support from Novartis, 23andMe is piloting a new program to educate its customers about the risks associated with high Lp(a). 23andMe customers will be able to purchase a confidential screening test for Lp(a) and will be provided the...

The newly launched Vascular Verification Program provides participating hospitals with a way to establish and grow quality improvement and clinical care infrastructure for vascular surgery and interventional care.